Synthetic Biology for Precision Fermentation of the Functional Food Ingredient Tagatose
Reference number | |
Coordinator | Galaxy Biosolutions AB |
Funding from Vinnova | SEK 1 000 000 |
Project duration | June 2024 - May 2025 |
Status | Completed |
Venture | Emerging technology solutions |
Call | Emerging technology solutions within quantum technology and synthetic biology 2024 |
Important results from the project
We have successfully developed genetic tools and constructed a yeast strain capable of producing tagatose from lactose in whey. The yeast strain was cultivated in lab-scale bioreactors using industrial whey as substrate. The process exceeded the set production targets, demonstrating strong potential for industrial-scale application. The results have provided a solid foundation for several new project proposals and have enabled both new and expanded collaborations with external partners.
Expected long term effects
The project has successfully demonstrated that fermentation-based tagatose production is feasible at the lab scale. The results provide a solid foundation for the next step – scaling up to pilot and industrial levels to evaluate production costs and environmental impact. A successful scale-up could enable cost-effective production of tagatose as a healthier sugar alternative and strengthen sustainable, fermentation-based food production in Sweden and beyond.
Approach and implementation
We first recruited a researcher for genetic tool development, and later another researcher was hired to support the optimization of the fermentation process. Through iterative strain engineering, a yeast strain was developed that demonstrated improved tagatose production from lactose in industrial whey in a 2-liter bioreactor, according to the project´s objective. Strong team spirit and flexible problem solving contributed to the success of the project despite some technical challenges.